Observational studySurgical endoscopy2026
VIsceral sheath targeted approach for left recurrent laryngeal nerve lymphadenectomy during robot-assisted minimally invasive esophagectomy (VISTA approach).
Observational study in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prognostic significance of recurrent laryngeal nerve lymph node dissection in esophageal squamous cell carcinoma: a systematic review and meta-analysis.Journal of thoracic disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLymphadenectomy along the left recurrent laryngeal nerve (RLN) is essential for curative esophagectomy but carries a high risk of RLN palsy, which impairs postoperative quality of life. Despite advances in robot-assisted minimally invasive esophagectomy (RAMIE), safe and radical dissection around the left RLN remains technically demanding. To achieve both oncological completeness and nerve preservation, we developed a novel Visceral sheath targeted approach (VISTA) based on precise anatomical understanding of the visceral and alar fasciae.
methodsThis retrospective observational study included 20 consecutive patients who underwent RAMIE with upper mediastinal lymphadenectomy using the VISTA approach for thoracic esophageal cancer between March 2024 and May 2025 at the Wakayama Medical University Hospital. RLN palsy was evaluated via bronchoscopy on postoperative day 1.
resultsNo postoperative RLN palsy (Clavien-Dindo ≥ I) was observed. The median number of dissected lymph nodes along the left RLN was four. Anastomotic leakage was observed in two patients (10%), and no other severe complications classified as Clavien-Dindo grade ≥ IIIa were observed.
conclusionThe VISTA approach has enabled anatomically guided, safe, and radical left RLN lymphadenectomy by stabilizing the nerve through the visceral sheath and expanding the operative field without traction. This technique may reduce RLN palsy while maintaining oncological precision, thereby offering a promising and reproducible procedure for upper mediastinal dissection in RAMIE.
Indexed as
Identifiers
41787084What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.